ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalazine API Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-20G13067
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalazine API Market Research Report 2023
BUY CHAPTERS

Global Mesalazine API Market Research Report 2025

Code: QYRE-Auto-20G13067
Report
March 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
PharmaZell GmbH
Syntese A/S
Cambrex Corporation
Chemi SPA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Mesalazine API Market Size

The global market for Mesalazine API was valued at US$ 186 million in the year 2024 and is projected to reach a revised size of US$ 239 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Mesalazine API Market

Mesalazine API Market

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine API.
The Mesalazine API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mesalazine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Mesalazine API Market Report

Report Metric Details
Report Name Mesalazine API Market
Accounted market size in year US$ 186 million
Forecasted market size in 2031 US$ 239 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Above 97 %
  • Above 98 %
  • Above 99 %
by Application
Production by Region
  • North America
  • Europe
  • China
  • India
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Mesalazine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Mesalazine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Mesalazine API Market growing?

Ans: The Mesalazine API Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Mesalazine API Market size in 2031?

Ans: The Mesalazine API Market size in 2031 will be US$ 239 million.

What is the market share of major companies in Mesalazine API Market?

Ans: The top 3 companies hold a share over 50%.

What is the Mesalazine API Market share by region?

Ans: Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

Who are the main players in the Mesalazine API Market report?

Ans: The main players in the Mesalazine API Market are PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical

What are the Application segmentation covered in the Mesalazine API Market report?

Ans: The Applications covered in the Mesalazine API Market report are Tablets, Capsules, Granule, Suppository, Enema, Others

What are the Type segmentation covered in the Mesalazine API Market report?

Ans: The Types covered in the Mesalazine API Market report are Above 97 %, Above 98 %, Above 99 %

Recommended Reports

API Market Reports

Colitis & IBD Drugs

Medical Conditions Focus

Market trends :

Topic Trends
Global rising global prevalence of inflammatory bowel disease and increasing diagnosis rates are driving sustained demand for mesalazine api, particularly in developed and emerging markets.
Type Above 97 % - demand for above 97% purity mesalazine api remains steady, driven by generic drug manufacturers seeking cost-effective formulations.
Above 98 % - above 98% purity mesalazine api is increasingly preferred for regulated markets due to stricter quality requirements.
Above 99 % - above 99% purity mesalazine api is gaining traction in premium and specialty formulations targeting advanced therapeutic outcomes.
Application Tablets - tablets remain the dominant application segment as oral administration is preferred for most mesalazine therapies.
Capsules - capsules are seeing moderate growth as patient preference for convenient dosage forms increases.
Granule - granule formulations are expanding in pediatric and geriatric markets due to ease of administration.
Suppository - suppository applications are stable, primarily used for targeted rectal delivery in ulcerative colitis.
Enema - enema formulations are utilized for localized treatment of distal ulcerative colitis, maintaining niche demand.
Company PharmaZell - pharmazell maintains strong production capacity and supply reliability, supporting its position as a key supplier to global pharmaceutical companies.
Syntese A - syntese a/s leverages advanced manufacturing and quality standards to retain significant market share in europe and globally.
Cambrex Corporation - cambrex corporation continues to expand its mesalazine api portfolio, focusing on compliance and supply chain resilience.
Region North America - north america experiences steady growth in mesalazine api demand due to high ibd prevalence and advanced healthcare infrastructure.
EMEA - europe remains the largest regional market, driven by established pharmaceutical manufacturing and rising ibd incidence.
APAC - apac is witnessing rapid demand growth, particularly in china and india, fueled by increasing ibd diagnosis and healthcare access.
LATAM - latam shows gradual uptake of mesalazine api as awareness and diagnosis of ibd improve across the region.
1 Mesalazine API Market Overview
1.1 Product Definition
1.2 Mesalazine API by Type
1.2.1 Global Mesalazine API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 97 %
1.2.3 Above 98 %
1.2.4 Above 99 %
1.3 Mesalazine API by Application
1.3.1 Global Mesalazine API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Market Growth Prospects
1.4.1 Global Mesalazine API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Mesalazine API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Mesalazine API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Mesalazine API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Mesalazine API Production Market Share by Manufacturers (2020-2025)
2.2 Global Mesalazine API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Mesalazine API, Industry Ranking, 2023 VS 2024
2.4 Global Mesalazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Mesalazine API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Mesalazine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Mesalazine API, Product Offered and Application
2.8 Global Key Manufacturers of Mesalazine API, Date of Enter into This Industry
2.9 Mesalazine API Market Competitive Situation and Trends
2.9.1 Mesalazine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Mesalazine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Mesalazine API Production by Region
3.1 Global Mesalazine API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Mesalazine API Production Value by Region (2020-2031)
3.2.1 Global Mesalazine API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Mesalazine API by Region (2026-2031)
3.3 Global Mesalazine API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Mesalazine API Production Volume by Region (2020-2031)
3.4.1 Global Mesalazine API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Mesalazine API by Region (2026-2031)
3.5 Global Mesalazine API Market Price Analysis by Region (2020-2025)
3.6 Global Mesalazine API Production and Value, Year-over-Year Growth
3.6.1 North America Mesalazine API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Mesalazine API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Mesalazine API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Mesalazine API Production Value Estimates and Forecasts (2020-2031)
4 Mesalazine API Consumption by Region
4.1 Global Mesalazine API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Mesalazine API Consumption by Region (2020-2031)
4.2.1 Global Mesalazine API Consumption by Region (2020-2025)
4.2.2 Global Mesalazine API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Mesalazine API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Mesalazine API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Mesalazine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Mesalazine API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Mesalazine API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Mesalazine API Production by Type (2020-2031)
5.1.1 Global Mesalazine API Production by Type (2020-2025)
5.1.2 Global Mesalazine API Production by Type (2026-2031)
5.1.3 Global Mesalazine API Production Market Share by Type (2020-2031)
5.2 Global Mesalazine API Production Value by Type (2020-2031)
5.2.1 Global Mesalazine API Production Value by Type (2020-2025)
5.2.2 Global Mesalazine API Production Value by Type (2026-2031)
5.2.3 Global Mesalazine API Production Value Market Share by Type (2020-2031)
5.3 Global Mesalazine API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Mesalazine API Production by Application (2020-2031)
6.1.1 Global Mesalazine API Production by Application (2020-2025)
6.1.2 Global Mesalazine API Production by Application (2026-2031)
6.1.3 Global Mesalazine API Production Market Share by Application (2020-2031)
6.2 Global Mesalazine API Production Value by Application (2020-2031)
6.2.1 Global Mesalazine API Production Value by Application (2020-2025)
6.2.2 Global Mesalazine API Production Value by Application (2026-2031)
6.2.3 Global Mesalazine API Production Value Market Share by Application (2020-2031)
6.3 Global Mesalazine API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 PharmaZell
7.1.1 PharmaZell Mesalazine API Company Information
7.1.2 PharmaZell Mesalazine API Product Portfolio
7.1.3 PharmaZell Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 PharmaZell Main Business and Markets Served
7.1.5 PharmaZell Recent Developments/Updates
7.2 Syntese A/S
7.2.1 Syntese A/S Mesalazine API Company Information
7.2.2 Syntese A/S Mesalazine API Product Portfolio
7.2.3 Syntese A/S Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Syntese A/S Main Business and Markets Served
7.2.5 Syntese A/S Recent Developments/Updates
7.3 Cambrex Corporation
7.3.1 Cambrex Corporation Mesalazine API Company Information
7.3.2 Cambrex Corporation Mesalazine API Product Portfolio
7.3.3 Cambrex Corporation Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Cambrex Corporation Main Business and Markets Served
7.3.5 Cambrex Corporation Recent Developments/Updates
7.4 Divis Laboratories
7.4.1 Divis Laboratories Mesalazine API Company Information
7.4.2 Divis Laboratories Mesalazine API Product Portfolio
7.4.3 Divis Laboratories Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Divis Laboratories Main Business and Markets Served
7.4.5 Divis Laboratories Recent Developments/Updates
7.5 Chemi SpA
7.5.1 Chemi SpA Mesalazine API Company Information
7.5.2 Chemi SpA Mesalazine API Product Portfolio
7.5.3 Chemi SpA Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Chemi SpA Main Business and Markets Served
7.5.5 Chemi SpA Recent Developments/Updates
7.6 Ipca Laboratories
7.6.1 Ipca Laboratories Mesalazine API Company Information
7.6.2 Ipca Laboratories Mesalazine API Product Portfolio
7.6.3 Ipca Laboratories Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Ipca Laboratories Main Business and Markets Served
7.6.5 Ipca Laboratories Recent Developments/Updates
7.7 Hangzhou Brother
7.7.1 Hangzhou Brother Mesalazine API Company Information
7.7.2 Hangzhou Brother Mesalazine API Product Portfolio
7.7.3 Hangzhou Brother Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Hangzhou Brother Main Business and Markets Served
7.7.5 Hangzhou Brother Recent Developments/Updates
7.8 Lianyungang Fengheng Biopharm
7.8.1 Lianyungang Fengheng Biopharm Mesalazine API Company Information
7.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolio
7.8.3 Lianyungang Fengheng Biopharm Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Lianyungang Fengheng Biopharm Main Business and Markets Served
7.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
7.9 Lasa Loboratory
7.9.1 Lasa Loboratory Mesalazine API Company Information
7.9.2 Lasa Loboratory Mesalazine API Product Portfolio
7.9.3 Lasa Loboratory Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Lasa Loboratory Main Business and Markets Served
7.9.5 Lasa Loboratory Recent Developments/Updates
7.10 Corden Pharma Bergamo
7.10.1 Corden Pharma Bergamo Mesalazine API Company Information
7.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolio
7.10.3 Corden Pharma Bergamo Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Corden Pharma Bergamo Main Business and Markets Served
7.10.5 Corden Pharma Bergamo Recent Developments/Updates
7.11 Erregierre SpA
7.11.1 Erregierre SpA Mesalazine API Company Information
7.11.2 Erregierre SpA Mesalazine API Product Portfolio
7.11.3 Erregierre SpA Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Erregierre SpA Main Business and Markets Served
7.11.5 Erregierre SpA Recent Developments/Updates
7.12 CTX Lifescience
7.12.1 CTX Lifescience Mesalazine API Company Information
7.12.2 CTX Lifescience Mesalazine API Product Portfolio
7.12.3 CTX Lifescience Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 CTX Lifescience Main Business and Markets Served
7.12.5 CTX Lifescience Recent Developments/Updates
7.13 Ishita Active Pharma Ingredients
7.13.1 Ishita Active Pharma Ingredients Mesalazine API Company Information
7.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolio
7.13.3 Ishita Active Pharma Ingredients Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Ishita Active Pharma Ingredients Main Business and Markets Served
7.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
7.14 YC Biotech (Jiangsu)
7.14.1 YC Biotech (Jiangsu) Mesalazine API Company Information
7.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolio
7.14.3 YC Biotech (Jiangsu) Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 YC Biotech (Jiangsu) Main Business and Markets Served
7.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
7.15 Xinxiang Tianfeng Fine Chemical
7.15.1 Xinxiang Tianfeng Fine Chemical Mesalazine API Company Information
7.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolio
7.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
7.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Mesalazine API Industry Chain Analysis
8.2 Mesalazine API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Mesalazine API Production Mode & Process Analysis
8.4 Mesalazine API Sales and Marketing
8.4.1 Mesalazine API Sales Channels
8.4.2 Mesalazine API Distributors
8.5 Mesalazine API Customer Analysis
9 Mesalazine API Market Dynamics
9.1 Mesalazine API Industry Trends
9.2 Mesalazine API Market Drivers
9.3 Mesalazine API Market Challenges
9.4 Mesalazine API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
FEATURED COMPANIES
PharmaZell GmbH
Syntese A/S
Cambrex Corporation
Chemi SPA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical
List of Tables
 Table 1. Global Mesalazine API Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Mesalazine API Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Mesalazine API Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Mesalazine API Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Mesalazine API Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Mesalazine API Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Mesalazine API Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Mesalazine API, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Mesalazine API as of 2024)
 Table 10. Global Market Mesalazine API Average Price by Manufacturers (US$/kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Mesalazine API, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Mesalazine API, Product Offered and Application
 Table 13. Global Key Manufacturers of Mesalazine API, Date of Enter into This Industry
 Table 14. Global Mesalazine API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalazine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Mesalazine API Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Mesalazine API Production Value Market Share by Region (2020-2025)
 Table 19. Global Mesalazine API Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Mesalazine API Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Mesalazine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Mesalazine API Production (Tons) by Region (2020-2025)
 Table 23. Global Mesalazine API Production Market Share by Region (2020-2025)
 Table 24. Global Mesalazine API Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Mesalazine API Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Mesalazine API Market Average Price (US$/kg) by Region (2020-2025)
 Table 27. Global Mesalazine API Market Average Price (US$/kg) by Region (2026-2031)
 Table 28. Global Mesalazine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Mesalazine API Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Mesalazine API Consumption Market Share by Region (2020-2025)
 Table 31. Global Mesalazine API Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Mesalazine API Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Mesalazine API Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Mesalazine API Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Mesalazine API Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Mesalazine API Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Mesalazine API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Mesalazine API Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Mesalazine API Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Mesalazine API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Mesalazine API Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Mesalazine API Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Mesalazine API Production (Tons) by Type (2020-2025)
 Table 46. Global Mesalazine API Production (Tons) by Type (2026-2031)
 Table 47. Global Mesalazine API Production Market Share by Type (2020-2025)
 Table 48. Global Mesalazine API Production Market Share by Type (2026-2031)
 Table 49. Global Mesalazine API Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Mesalazine API Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Mesalazine API Production Value Market Share by Type (2020-2025)
 Table 52. Global Mesalazine API Production Value Market Share by Type (2026-2031)
 Table 53. Global Mesalazine API Price (US$/kg) by Type (2020-2025)
 Table 54. Global Mesalazine API Price (US$/kg) by Type (2026-2031)
 Table 55. Global Mesalazine API Production (Tons) by Application (2020-2025)
 Table 56. Global Mesalazine API Production (Tons) by Application (2026-2031)
 Table 57. Global Mesalazine API Production Market Share by Application (2020-2025)
 Table 58. Global Mesalazine API Production Market Share by Application (2026-2031)
 Table 59. Global Mesalazine API Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Mesalazine API Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Mesalazine API Production Value Market Share by Application (2020-2025)
 Table 62. Global Mesalazine API Production Value Market Share by Application (2026-2031)
 Table 63. Global Mesalazine API Price (US$/kg) by Application (2020-2025)
 Table 64. Global Mesalazine API Price (US$/kg) by Application (2026-2031)
 Table 65. PharmaZell Mesalazine API Company Information
 Table 66. PharmaZell Mesalazine API Specification and Application
 Table 67. PharmaZell Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 68. PharmaZell Main Business and Markets Served
 Table 69. PharmaZell Recent Developments/Updates
 Table 70. Syntese A/S Mesalazine API Company Information
 Table 71. Syntese A/S Mesalazine API Specification and Application
 Table 72. Syntese A/S Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Syntese A/S Main Business and Markets Served
 Table 74. Syntese A/S Recent Developments/Updates
 Table 75. Cambrex Corporation Mesalazine API Company Information
 Table 76. Cambrex Corporation Mesalazine API Specification and Application
 Table 77. Cambrex Corporation Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Cambrex Corporation Main Business and Markets Served
 Table 79. Cambrex Corporation Recent Developments/Updates
 Table 80. Divis Laboratories Mesalazine API Company Information
 Table 81. Divis Laboratories Mesalazine API Specification and Application
 Table 82. Divis Laboratories Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Divis Laboratories Main Business and Markets Served
 Table 84. Divis Laboratories Recent Developments/Updates
 Table 85. Chemi SpA Mesalazine API Company Information
 Table 86. Chemi SpA Mesalazine API Specification and Application
 Table 87. Chemi SpA Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Chemi SpA Main Business and Markets Served
 Table 89. Chemi SpA Recent Developments/Updates
 Table 90. Ipca Laboratories Mesalazine API Company Information
 Table 91. Ipca Laboratories Mesalazine API Specification and Application
 Table 92. Ipca Laboratories Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Ipca Laboratories Main Business and Markets Served
 Table 94. Ipca Laboratories Recent Developments/Updates
 Table 95. Hangzhou Brother Mesalazine API Company Information
 Table 96. Hangzhou Brother Mesalazine API Specification and Application
 Table 97. Hangzhou Brother Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Hangzhou Brother Main Business and Markets Served
 Table 99. Hangzhou Brother Recent Developments/Updates
 Table 100. Lianyungang Fengheng Biopharm Mesalazine API Company Information
 Table 101. Lianyungang Fengheng Biopharm Mesalazine API Specification and Application
 Table 102. Lianyungang Fengheng Biopharm Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Lianyungang Fengheng Biopharm Main Business and Markets Served
 Table 104. Lianyungang Fengheng Biopharm Recent Developments/Updates
 Table 105. Lasa Loboratory Mesalazine API Company Information
 Table 106. Lasa Loboratory Mesalazine API Specification and Application
 Table 107. Lasa Loboratory Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Lasa Loboratory Main Business and Markets Served
 Table 109. Lasa Loboratory Recent Developments/Updates
 Table 110. Corden Pharma Bergamo Mesalazine API Company Information
 Table 111. Corden Pharma Bergamo Mesalazine API Specification and Application
 Table 112. Corden Pharma Bergamo Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Corden Pharma Bergamo Main Business and Markets Served
 Table 114. Corden Pharma Bergamo Recent Developments/Updates
 Table 115. Erregierre SpA Mesalazine API Company Information
 Table 116. Erregierre SpA Mesalazine API Specification and Application
 Table 117. Erregierre SpA Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 118. Erregierre SpA Main Business and Markets Served
 Table 119. Erregierre SpA Recent Developments/Updates
 Table 120. CTX Lifescience Mesalazine API Company Information
 Table 121. CTX Lifescience Mesalazine API Specification and Application
 Table 122. CTX Lifescience Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 123. CTX Lifescience Main Business and Markets Served
 Table 124. CTX Lifescience Recent Developments/Updates
 Table 125. Ishita Active Pharma Ingredients Mesalazine API Company Information
 Table 126. Ishita Active Pharma Ingredients Mesalazine API Specification and Application
 Table 127. Ishita Active Pharma Ingredients Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 128. Ishita Active Pharma Ingredients Main Business and Markets Served
 Table 129. Ishita Active Pharma Ingredients Recent Developments/Updates
 Table 130. YC Biotech (Jiangsu) Mesalazine API Company Information
 Table 131. YC Biotech (Jiangsu) Mesalazine API Specification and Application
 Table 132. YC Biotech (Jiangsu) Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 133. YC Biotech (Jiangsu) Main Business and Markets Served
 Table 134. YC Biotech (Jiangsu) Recent Developments/Updates
 Table 135. Xinxiang Tianfeng Fine Chemical Mesalazine API Company Information
 Table 136. Xinxiang Tianfeng Fine Chemical Mesalazine API Specification and Application
 Table 137. Xinxiang Tianfeng Fine Chemical Mesalazine API Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 138. Xinxiang Tianfeng Fine Chemical Main Business and Markets Served
 Table 139. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Mesalazine API Distributors List
 Table 143. Mesalazine API Customers List
 Table 144. Mesalazine API Market Trends
 Table 145. Mesalazine API Market Drivers
 Table 146. Mesalazine API Market Challenges
 Table 147. Mesalazine API Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalazine API
 Figure 2. Global Mesalazine API Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Mesalazine API Market Share by Type: 2024 VS 2031
 Figure 4. Above 97 % Product Picture
 Figure 5. Above 98 % Product Picture
 Figure 6. Above 99 % Product Picture
 Figure 7. Global Mesalazine API Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Mesalazine API Market Share by Application: 2024 VS 2031
 Figure 9. Tablets
 Figure 10. Capsules
 Figure 11. Granule
 Figure 12. Suppository
 Figure 13. Enema
 Figure 14. Others
 Figure 15. Global Mesalazine API Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Mesalazine API Production Value (US$ Million) & (2020-2031)
 Figure 17. Global Mesalazine API Production Capacity (Tons) & (2020-2031)
 Figure 18. Global Mesalazine API Production (Tons) & (2020-2031)
 Figure 19. Global Mesalazine API Average Price (US$/kg) & (2020-2031)
 Figure 20. Mesalazine API Report Years Considered
 Figure 21. Mesalazine API Production Share by Manufacturers in 2024
 Figure 22. Global Mesalazine API Production Value Share by Manufacturers (2024)
 Figure 23. Mesalazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. The Global 5 and 10 Largest Players: Market Share by Mesalazine API Revenue in 2024
 Figure 25. Global Mesalazine API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 26. Global Mesalazine API Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 27. Global Mesalazine API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 28. Global Mesalazine API Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 29. North America Mesalazine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Europe Mesalazine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 31. China Mesalazine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 32. India Mesalazine API Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 33. Global Mesalazine API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 34. Global Mesalazine API Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 35. North America Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. North America Mesalazine API Consumption Market Share by Country (2020-2031)
 Figure 37. U.S. Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. Canada Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. Europe Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Europe Mesalazine API Consumption Market Share by Country (2020-2031)
 Figure 41. Germany Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. France Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. U.K. Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Italy Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Russia Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Asia Pacific Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. Asia Pacific Mesalazine API Consumption Market Share by Region (2020-2031)
 Figure 48. China Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Japan Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. South Korea Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. China Taiwan Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Southeast Asia Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. India Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Latin America, Middle East & Africa Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Latin America, Middle East & Africa Mesalazine API Consumption Market Share by Country (2020-2031)
 Figure 56. Mexico Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Brazil Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 58. Turkey Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 59. GCC Countries Mesalazine API Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 60. Global Production Market Share of Mesalazine API by Type (2020-2031)
 Figure 61. Global Production Value Market Share of Mesalazine API by Type (2020-2031)
 Figure 62. Global Mesalazine API Price (US$/kg) by Type (2020-2031)
 Figure 63. Global Production Market Share of Mesalazine API by Application (2020-2031)
 Figure 64. Global Production Value Market Share of Mesalazine API by Application (2020-2031)
 Figure 65. Global Mesalazine API Price (US$/kg) by Application (2020-2031)
 Figure 66. Mesalazine API Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Mesalazine Market Research Report 2024
Oral Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalamine Market Research Report 2024
Global Mesalamine API Market Research Report 2024
Rectal Mesalazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
5 aminosalicylic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalazine Suppositories Market Research Report 2024
Mesalamine Lialda Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug for Ulcerative Colitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ulcerative Colitis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Balsalazide Disodium Market Research Report 2025
Global Aminosalicylic Acid Preparation Market Insights Forecast to 2030
Global Adalimumab Market Insights Forecast to 2030
Global Small Molecules Drugs for Inflammatory Bowel Diseases IBDs Market Research Report 2024
Global Sodium 4 Aminosalicylate Market Research Report 2024
Vesanoid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mesalazine Enteric Coated Tablets Market Research Report 2024
Global Sulfadimidine and Sodium Salt Market Research Report 2024
Global Sulfapyridine Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions